References
- Farmakis D, Mueller C, Apple FS. High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population. Eur Heart J. 2020;41(41):1–9. Available at https://pubmed.ncbi.nlm.nih.gov/32077940/ doi: 10.1093/eurheartj/ehaa083.
- Daniels LB, Maisel AS. Cardiovascular biomarkers and sex: the case for women. Nat Rev Cardiol. 2015;12(10):588–596. Available from https://pubmed.ncbi.nlm.nih.gov/26149486/ doi: 10.1038/nrcardio.2015.105.
- Wang YX, Arvizu M, Rich-Edwards JW, et al. Menstrual cycle regularity and length across the reproductive lifespan and risk of premature mortality: prospective cohort study. BMJ. 2020;371:m3464. Available at https://pubmed.ncbi.nlm.nih.gov/32998909/ doi: 10.1136/bmj.m3464.
- Berni TR, Morgan CL, Aled Rees D. Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study. J Clin Endocrinol Metab. 2021;106(9):E3369–E3380. doi: 10.1210/clinem/dgab392.
- Zhao D, Guallar E, Ouyang P, et al. Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Am Coll Cardiol. 2018;71(22):2555–2566. Available at https://pubmed.ncbi.nlm.nih.gov/29852978/ doi: 10.1016/j.jacc.2018.01.083.
- Lew J, Sanghavi M, Ayers CR, et al. Sex-based differences in cardiometabolic biomarkers. Circulation. 2017;135(6):544–555. Available at https://pubmed.ncbi.nlm.nih.gov/28153991/ doi: 10.1161/CIRCULATIONAHA.116.023005.
- Nordström T, Miettunen J, Auvinen J, et al. Cohort profile: 46 years of follow-up of the Northern Finland birth cohort 1966 (NFBC1966). Int J Epidemiol. 2022;50(6):1786–1787j. doi: 10.1093/ije/dyab109.
- University of Oulu. University of Oulu: Northern Finland Birth Cohort; 1966.
- Piltonen TT, Komsi E, Morin-Papunen LC, et al. AMH as part of the diagnostic PCOS workup in large epidemiological studies. Eur J Endocrinol. 2023;188(6):547–554. Available at https://pubmed.ncbi.nlm.nih.gov/37294941/ doi: 10.1093/ejendo/lvad065.
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43–G64. Available at https://pubmed.ncbi.nlm.nih.gov/37580861/ doi: 10.1093/ejendo/lvad096.
- West S, Vähäsarja M, Bloigu A, et al. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland birth cohort 1966. Hum Reprod. 2014;29(3):628–633. doi: 10.1093/humrep/det437.
- West S, Ollila MM, Franks S, et al. Overweight, obesity and hyperandrogenemia are associated with gestational diabetes mellitus: a follow-up cohort study. Acta Obstet Gynecol Scand. 2020;99(10):1311–1319. Available at https://pubmed.ncbi.nlm.nih.gov/32333801/ doi: 10.1111/aogs.13883.
- Rantakallio JSS, Nevalainen JE, West SI, et al. Association of self-reported polycystic ovary syndrome, obesity, and weight gain from adolescence to adulthood with hypertensive disorders of pregnancy: a community-based approach. Hypertension. 2021;77(3):1010–1019. Available at https://pubmed.ncbi.nlm.nih.gov/33517680/ doi: 10.1161/HYPERTENSIONAHA.120.15702.
- Webber L, Davies M, Anderson R, et al. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926–937. Available at https://pubmed.ncbi.nlm.nih.gov/27008889/
- Ollila MME, Kaikkonen K, Järvelin MR, et al. Self-reported polycystic ovary syndrome is associated with hypertension: a Northern Finland birth cohort 1966 study. J Clin Endocrinol Metab. 2019;104(4):1221–1231. doi: 10.1210/jc.2018-00570.
- Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–1463. Available at https://pubmed.ncbi.nlm.nih.gov/16376782/ doi: 10.1016/j.echo.2005.10.005.
- Saenger AK, Beyrau R, Braun S, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011;412(9–10):748–754. Available at https://pubmed.ncbi.nlm.nih.gov/21219893/ doi: 10.1016/j.cca.2010.12.034.
- Wu AHB, Christenson RH, Greene DN, et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2018;64(4):645–655. Available at https://pubmed.ncbi.nlm.nih.gov/29343532/ doi: 10.1373/clinchem.2017.277186.
- Huang J, Liu M, Su E, et al. Elevated circulating high-sensitivity cardiac troponin T and cardiac remodeling in obesity. BMC Cardiovasc Disord. 2021;21(1):620. Available at https://pubmed.ncbi.nlm.nih.gov/34963447/ doi: 10.1186/s12872-021-02445-0.
- Ollila MM, Arffman RK, Korhonen E, et al. Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study. Eur J Endocrinol. 2023;189(1):96–105. Available at https://pubmed.ncbi.nlm.nih.gov/37436934/ doi: 10.1093/ejendo/lvad077.
- Ollila MM, Piltonen TT, Tapanainen JS, et al. Aging women with polycystic ovary syndrome: menstrual cycles, metabolic health, and health-related quality of life. Curr Opin Endocr Metab Res. 2020;12:14–19. doi: 10.1016/j.coemr.2020.02.010.
- Oliver-Williams C, Glisic M, Shahzad S, et al. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Hum Reprod Update. 2019;25(2):257–271. Available at https://pubmed.ncbi.nlm.nih.gov/30508190/ doi: 10.1093/humupd/dmy039.
- Lyngbakken MN, Skranes JB, De Lemos JA, et al. Impact of smoking on circulating cardiac troponin I concentrations and cardiovascular events in the general population: the HUNT study (Nord-Trøndelag health study). Circulation. 2016;134(24):1962–1972. Available at https://pubmed.ncbi.nlm.nih.gov/27815376/ doi: 10.1161/CIRCULATIONAHA.116.023726.
- Nadruz W, Gonçalves A, Claggett B, et al. Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk In Communities (ARIC) study. Eur J Heart Fail. 2016;18(6):629–637. Available at https://pubmed.ncbi.nlm.nih.gov/27030444/ doi: 10.1002/ejhf.511.
- Lazo M, Chen Y, McEvoy JW, et al. Alcohol consumption and cardiac biomarkers: the Atherosclerosis Risk In Communities (ARIC) study. Clin Chem. 2016;62(9):1202–1210. Available at https://pubmed.ncbi.nlm.nih.gov/27440513/ doi: 10.1373/clinchem.2016.255778.
- Jaffe AS, Vasile VC, Milone M, et al. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011;58(17):1819–1824. Available at https://pubmed.ncbi.nlm.nih.gov/21962825/ doi: 10.1016/j.jacc.2011.08.026.